Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Experimental”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05319730
What this trial is testing

Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLC 230
Not applicableStudy completedNCT03378895
What this trial is testing

CEPPPIA Pilot. Experimental Center of Participative and Individualized Predictive Prevention in Auvergne

Who this might be right for
Chronic DiseaseCardiovascular DiseasesCancers+2 more
University Hospital, Clermont-Ferrand 251
Testing effectiveness (Phase 2)Looking for participantsNCT05287945
What this trial is testing

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Oncorena AB 75
Testing effectiveness (Phase 2)Study completedNCT00806286
What this trial is testing

Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Daiichi Sankyo 111
Testing effectiveness (Phase 2)Study completedNCT04303169
What this trial is testing

Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma Who Are Candidates for Neoadjuvant Therapy (MK-3475-02C/KEYMAKER-U02)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 146
Testing effectiveness (Phase 2)Study completedNCT00097929
What this trial is testing

An Investigational Drug Study With Suberoylanilide Hydroxamic Acid in Relapsed Diffuse Large B-cell Lymphoma (0683-013)

Who this might be right for
B-cell Lymphoma
Merck Sharp & Dohme LLC 18
Early research (Phase 1)Study completedNCT00557856
What this trial is testing

A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Pfizer 70
Testing effectiveness (Phase 2)Looking for participantsNCT07297212
What this trial is testing

A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
BioNTech SE 75
Testing effectiveness (Phase 2)Ended earlyNCT03351231
What this trial is testing

An Investigational Immuno-Therapy Study of Experimental Medication BMS-986242 Given in Combination With Nivolumab in Patients With Advanced Cancer

Who this might be right for
Cancer
Bristol-Myers Squibb 7